pinoresinol has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, E; Choon Lee, Y; Hoon Ryu, J; Hyun Cho, J; Hyun Kim, D; Jeon, J; Jin Park, S; Jun, M; Kim, JS; Kwon Park, J; Kwon, H; Lee, J; Lee, S; Moon, M; Seong Sin, J; Woong Choi, J; Yu, J | 1 |
1 other study(ies) available for pinoresinol and Alzheimer Disease
| Article | Year |
|---|---|
Akt and calcium-permeable AMPA receptor are involved in the effect of pinoresinol on amyloid β-induced synaptic plasticity and memory deficits.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Furans; Hippocampus; Lignans; Long-Term Potentiation; Male; Memory Disorders; Mice, Inbred Strains; Neuronal Plasticity; Peptide Fragments; Proto-Oncogene Proteins c-akt; Receptors, AMPA | 2021 |